Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer-Reference-Cited by-同舟云学术

Competing Nomogram for Late-Period Breast Cancer-Specific Death in Patients with Early-Stage Hormone Receptor-Positive Breast Cancer

Published:2021-08 Issue: Volume: Page:
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Zhu Jingjing,Zheng Hongjuan,Ge Chenyang,Lin Haiping,Yu Kaijie,Wu Lunpo,Li Dan,Zhou Shishi,Tang Wanfen,Wang Qinghua,Zhang Xia,Jin Xiayun,Xu Xifeng,Du Jinlin,Fu Jianfei^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Early breast cancer trialists’ collaborative g: effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Abe;Lancet,2005

2. Annual hazard rates of recurrence for breast cancer after primary therapy;Saphner;J Clin Oncol,1996

3. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial;Cuzick;Lancet Oncol,2010

4. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up;Regan;Lancet Oncol,2011

5. Extended adjuvant endocrine therapy in hormone-receptor-positive early breast cancer;O’Leary;Curr Opin Oncol,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Spät-Sterberisiko nach hormonrezeptorpositivem Mammakarzinom;Senologie - Zeitschrift für Mammadiagnostik und -therapie;2022-12

2. Spät-Sterberisiko nach hormonrezeptorpositivem Mammakarzinom;Geburtshilfe und Frauenheilkunde;2022-07